Guizhou Xinbang Pharmaceutical Co Ltd (002390) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.034x

Based on the latest financial reports, Guizhou Xinbang Pharmaceutical Co Ltd (002390) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥234.19 Million ≈ $34.27 Million USD) by net assets (CN¥6.97 Billion ≈ $1.02 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View current stock price of Guizhou Xinbang Pharmaceutical Co Ltd for real-time trading data and today's change.

Guizhou Xinbang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Guizhou Xinbang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see 002390 stock market capitalisation for the company's overall valuation and market capitalisation.

Guizhou Xinbang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guizhou Xinbang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see total assets of Guizhou Xinbang Pharmaceutical Co Ltd for a full breakdown of the balance sheet.

Company	Cash Flow Conversion Efficiency
Scandinavian Tobacco Group A/S CO:STG	0.017x
Guangdong Lvtong New Energy Electric Vehicle Technology Co. Ltd. Cl A SHE:301322	N/A
SG Fleet Group Ltd AU:SGF	-0.064x
Niutech Environment Technology Corp SHG:688309	0.063x
PWR Holdings Ltd AU:PWH	0.100x
Shenzhen Feima International Supply Chain Co Ltd SHE:002210	0.042x
DBV Technologies S.A. PA:DBV	-0.236x
S.J.S. Enterprises Limited NSE:SJS	0.122x

Annual Cash Flow Conversion Efficiency for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Guizhou Xinbang Pharmaceutical Co Ltd from 2006 to 2024. Review how financially flexible is Guizhou Xinbang Pharmaceutical Co Ltd to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥7.02 Billion ≈ $1.03 Billion	CN¥634.97 Million ≈ $92.92 Million	0.090x	-18.29%
2023-12-31	CN¥7.14 Billion ≈ $1.05 Billion	CN¥790.62 Million ≈ $115.69 Million	0.111x	+32.38%
2022-12-31	CN¥7.07 Billion ≈ $1.03 Billion	CN¥590.80 Million ≈ $86.45 Million	0.084x	+24.68%
2021-12-31	CN¥6.83 Billion ≈ $999.22 Million	CN¥457.97 Million ≈ $67.02 Million	0.067x	-53.29%
2020-12-31	CN¥5.17 Billion ≈ $756.31 Million	CN¥742.11 Million ≈ $108.59 Million	0.144x	-18.22%
2019-12-31	CN¥5.05 Billion ≈ $738.73 Million	CN¥886.33 Million ≈ $129.70 Million	0.176x	+515.18%
2018-12-31	CN¥5.17 Billion ≈ $756.32 Million	CN¥-218.56 Million ≈ $-31.98 Million	-0.042x	-241.67%
2017-12-31	CN¥6.76 Billion ≈ $989.00 Million	CN¥201.74 Million ≈ $29.52 Million	0.030x	+197.48%
2016-12-31	CN¥6.49 Billion ≈ $948.96 Million	CN¥-198.59 Million ≈ $-29.06 Million	-0.031x	-137.59%
2015-12-31	CN¥2.67 Billion ≈ $390.56 Million	CN¥217.40 Million ≈ $31.81 Million	0.081x	+200.81%
2014-12-31	CN¥2.46 Billion ≈ $359.67 Million	CN¥-198.60 Million ≈ $-29.06 Million	-0.081x	-292.27%
2013-12-31	CN¥1.04 Billion ≈ $151.59 Million	CN¥-21.34 Million ≈ $-3.12 Million	-0.021x	+42.23%
2012-12-31	CN¥1.02 Billion ≈ $149.64 Million	CN¥-36.46 Million ≈ $-5.34 Million	-0.036x	+12.39%
2011-12-31	CN¥979.53 Million ≈ $143.34 Million	CN¥-39.87 Million ≈ $-5.83 Million	-0.041x	-1661.76%
2010-12-31	CN¥959.70 Million ≈ $140.43 Million	CN¥2.50 Million ≈ $365.97K	0.003x	-98.42%
2009-12-31	CN¥252.83 Million ≈ $37.00 Million	CN¥41.75 Million ≈ $6.11 Million	0.165x	+37.96%
2008-12-31	CN¥207.69 Million ≈ $30.39 Million	CN¥24.86 Million ≈ $3.64 Million	0.120x	-35.86%
2007-12-31	CN¥174.08 Million ≈ $25.47 Million	CN¥32.49 Million ≈ $4.75 Million	0.187x	+266.24%
2006-12-31	CN¥144.17 Million ≈ $21.10 Million	CN¥7.35 Million ≈ $1.07 Million	0.051x	--

About Guizhou Xinbang Pharmaceutical Co Ltd

SHE:002390 China Drug Manufacturers - Specialty & Generic

Market Cap

$864.72 Million

CN¥5.91 Billion CNY

Market Cap Rank

#9588 Global

#2419 in China

Share Price

CN¥3.04

Change (1 day)

-3.80%

52-Week Range

CN¥2.60 - CN¥4.15

All Time High

CN¥14.40